IOVANDA Trademark

Trademark Overview

On Thursday, December 20, 2018, a trademark application was filed for IOVANDA with the United States Patent and Trademark Office. The USPTO has given the IOVANDA trademark a serial number of 88237412. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, August 16, 2022. This trademark is owned by CytomX Therapeutics, Inc.. The IOVANDA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
iovanda

General Information

Serial Number88237412
Word MarkIOVANDA
Filing DateThursday, December 20, 2018
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, August 16, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, August 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCytomX Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameCytomX Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, August 16, 2022ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, August 16, 2022ABANDONMENT - AFTER PUBLICATION
Monday, August 15, 2022TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, August 11, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 11, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 11, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 11, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 11, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 27, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 8, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, June 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 9, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, August 11, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, November 10, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, April 28, 2020REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 16, 2019REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 16, 2019ASSIGNED TO LIE
Wednesday, June 12, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 28, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, March 28, 2019LETTER OF SUSPENSION E-MAILED
Thursday, March 28, 2019SUSPENSION LETTER WRITTEN
Friday, March 15, 2019ASSIGNED TO EXAMINER
Sunday, January 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 24, 2018NEW APPLICATION ENTERED

Related Keywords

iovanda cancer treatment preparations pharmaceutical